GrowPros Cannabis offers a bridge between medicinal marihuana companies and institutional financing
January 6, 2015 — In a special InvestorIntel interview, Publisher Tracy Weslosky speaks with Ryan Brown, CEO of GrowPros Cannabis Ventures Inc. (CSE: GCI) about the recent merger between Mazorro and GrowPros and their acquisition mandate for 2015
Tracy Weslosky: You just recently made an announcement about a merger that you made, yes? Mazzoro is now GrowPros Cannabis Ventures — can you tell us a little bit about this?
Ryan Brown: We were looking for a public vehicle to enter into the marijuana space and they were looking for an entity to bring into their company as they diversified into the cannabis industry so it was a perfect match. We’re a good fit. Everything has been working out great so far.
Tracy Weslosky: When I was looking at your overall business model Ryan, I think there were 27 million shares outstanding and with this merger you now have 50 million shares. Is this correct?
Ryan Brown: Yes, that’s correct.
Get our daily investorintel update
Tracy Weslosky: It’s also my understanding that your company is going to be seeking new acquisitions. Is this correct?
Ryan Brown: Absolutely. We see ourselves as a bridge between companies that are currently operating within the cannabis industry and institutional financing as well as companies that are looking to get into the medical marijuana industry that really don’t have a frame of reference. They don’t have the background to properly position themselves in this new and emerging industry and with our background and the team that we’ve assembled at GrowPros Cannabis Ventures we’ve had some very good feedback from companies that we’re working with, working on developing some joint ventures with to help them get into the newly budding cannabis industry.
Tracy Weslosky: Of course, everybody’s got the race for a medicinal marijuana license. Where are you in the process?
Ryan Brown: We are currently working on two applications; one that is in the preliminary process, but it’s actually moved quite quickly considering it was a later application. We’re working with another one that has a ready to build facility that we’re able to start construction hopefully first quarter of 2015.
Tracy Weslosky: For all of you out there in InvestorIntel audience you’re wondering what’s really happening with the medicinal marijuana. I’d like you to give us a little bit of an overview about the sector and why we should invest in your company.
Ryan Brown: Well, obviously the first initial rush was the rush to get the coveted MMPR production license through Health Canada. I think as the market has observed the economics of running these large highly regulated production facilities is a little more difficult at this infancy stage of the industry so we took the stance of wanting to create a diversified public vehicle that will be investing in all areas of the medical marijuana business. In a brand new industry no one knows which way this industry is going to go and we feel that having flexibility and being well diversified in the industry will yield the best returns for our investors…to see the rest of the GrowPros Cannabis Ventures interview, click here
Disclaimer: GrowPros Cannabis Ventures is an advertorial member of InvestorIntel.
An accomplished entrepreneur and corporate finance professional, Tracy Weslosky is the CEO for InvestorIntel Corp. and the VP of Business Development for Bellotti Capital Partners ... <Read more about Tracy Weslosky>